Analysts See $1.55 EPS for Walgreens Boots Alliance, Inc. (WBA)

March 14, 2018 - By Henry Gaston

 Analysts See $1.55 EPS for Walgreens Boots Alliance, Inc. (WBA)

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.55 EPS on March, 28 before the open.They anticipate $0.19 EPS change or 13.97 % from last quarter’s $1.36 EPS. WBA’s profit would be $1.54B giving it 11.06 P/E if the $1.55 EPS is correct. After having $1.28 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see 21.09 % EPS growth. The stock decreased 1.88% or $1.31 during the last trading session, reaching $68.55. About 4.29 million shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has risen 5.77% since March 15, 2017 and is uptrending. It has underperformed by 10.93% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 22 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Walgreens Boots Alliance had 55 analyst reports since August 24, 2015 according to SRatingsIntel. Jefferies upgraded the stock to “Buy” rating in Monday, October 17 report. Leerink Swann maintained the stock with “Buy” rating in Thursday, July 20 report. The firm has “Buy” rating given on Wednesday, August 23 by UBS. The stock has “Buy” rating by Loop Capital Markets on Thursday, August 24. The company was maintained on Thursday, October 19 by Robert W. Baird. The stock has “Buy” rating by RBC Capital Markets on Wednesday, October 28. As per Wednesday, June 21, the company rating was maintained by Jefferies. Zacks downgraded Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on Monday, August 24 to “Buy” rating. The firm earned “Buy” rating on Tuesday, October 24 by Mizuho. Mizuho maintained it with “Buy” rating and $87.0 target in Wednesday, January 24 report.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $67.91 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 18.91 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More notable recent Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news were published by: which released: “Rite Aid Announces Continued Progress in Sale of Assets to Walgreens Boots …” on March 05, 2018, also with their article: “Walgreens Boots Alliance appoints James Kehoe Global CFO” published on March 08, 2018, published: “Walgreens Boots Alliance – What Keeps The Stock From Going Up?” on March 12, 2018. More interesting news about Walgreens Boots Alliance, Inc. (NASDAQ:WBA) were released by: and their article: “Should Value Investors Pick Walgreens Boots Alliance (WBA) Stock?” published on February 27, 2018 as well as‘s news article titled: “Walgreens Boots Alliance, Inc. (WBA) Ex-Dividend Date Scheduled for February …” with publication date: February 13, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: